Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey.

CONCLUSION: M-MBC strategy still has controversial issues and its potential clinical effects for breast cancer patients need ad hoc studies.
PMID: 29679936 [PubMed - as supplied by publisher]

Source: Breast - April 18, 2018 Category: Cancer & Oncology Authors: Marta B, Debora B, Lorenzo G, Giacomo P, Michele B, Grazia VM, Valentina F, Camilla L, Mauro M, Marco MA, Giuseppe A, Michele L, Filippo M, Lucia DM, Fabio P Tags: Breast Source Type: research